Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP)

Annals of Indian Academy of Neurology

Volumn 18, Issue 1, 2015, Pages 49-59

  Sharma, Ashish ^a   Goyal, Vinay ^a   Behari, Madhuri ^a   Srivastva, Achal ^a   Shukla, Garima ^a   Vibha, Deepti ^a  

^a Dr Rajendra Prasad Governent Medical College and Hospital   (India)

Author keywords

impulse control disorder related compulsive behaviour disorders; Impulse control disorders; Parkinson's disease; QUIP

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; ROTIGOTINE; SELEGILINE; TOLCAPONE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR ASSESSMENT; COMPARATIVE STUDY; COMPULSIVE EATING; COMPULSIVE HOBBYISM; COMPULSIVE MEDICATION USE; COMPULSIVE PERSONALITY DISORDER; COMPULSIVE SHOPPING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG USE; EATING DISORDER; FEMALE; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; IMPULSE CONTROL DISORDER AND RELATED BEHAVIOR; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; ONSET AGE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PREVALENCE; PUNDING; QUESTIONNAIRE FOR IMPULSIVE COMPULSIVE DISORDER IN PARKINSON DISEASE; SHOPPING; SINGLE (MARITAL STATUS); SMOKING; SUBSTITUTION THERAPY; TREATMENT DURATION; WALKABOUT; WALKING;

EID: 84922989465     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.144311     Document Type: Article

References (17)

1. Diagnostic and Statistical Manual of Mental Disorders Source Information [Internet]. Available from: http://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/DSM4/[Last accessed 2013 Aug 28].
2. Callesen MB, Scheel-Krüger J, Kringelbach ML, Møller A. A systematic review of impulse control disorders in Parkinson's disease. J Parkinsons Dis 2013;3:105-38.
3. Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009;24:1461-7.
4. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-53.
5. Papay K, Mamikonyan E, Siderowf AD, Duda JE, Lyons KE, Pahwa R, et al. Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: Validity and variability. Parkinsonism Relat Disord 2011;17:153-5.
6. Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-95.
7. Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism Relat Disord 2012;18:155-60.
8. Perez-Lloret S, Rey MV, Fabre N, Ory F, Spampinato U, Brefel-Courbon C, et al. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Clin Neuropharmacol 2012;35:261-5.
9. Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010;16:202-7.
10. Auyeung M, Tsoi TH, Tang WK, Cheung CM, Lee CN, Li R, et al. Impulse control disorders in Chinese Parkinson's disease patients: The effect of ergot derived dopamine agonist. Parkinsonism Relat Disord 2011;17:635-7.
11. Lim SY, Tan ZK, Ngam PI, Lor TL, Mohamed H, Schee JP, et al. Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients: Assessment using the QUIP. Parkinsonism Relat Disord 2011;17:761-4.
12. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007;22:1757-63.
13. Sarathchandran P, Soman S, Sarma G, Krishnan S, Kishore A. Impulse control disorders and related behaviors in Indian patients with Parkinson's disease. Mov Disord 2013;28:1901-2.
14. Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, et al. Chronic dopaminergic stimulation in Parkinson's disease: From dyskinesias to impulse control disorders. Lancet Neurol 2009;8:1140-9.
15. Lim SY, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson's disease: Review. Ann N Y Acad Sci 2008;1142:85-107.
16. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63:969-73.
17. Valencą GT, Glass PG, Negreiros NN, Duarte MB, Ventura LM, Mueller M, et al. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord 2013;19:698-700.